Seventeenth Report of Session 2012-13 - Statutory Instruments Joint Committee Contents


Appendix 3


S.I. 2012/3032: memorandum from the Department for Business, Innovation and Skills


Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Regulations 2012 (S.I. 2012/3032)


1.  By a letter dated 16 January 2013, the Committee requested a memorandum on points 1 and 2 set out below in relation to these Regulations.

(1)  Explain, with reference if possible to an example of requirements of other legislation that are "at least as stringent" as those in regulation 18, but satisfaction of which would not also in fact satisfy the requirements of regulation 18 (but for regulation 18(3))—

(a)  what effect regulation 18(3) is intended to achieve, and

(b)  how the intended effect is achieved.

(2)  Explain, with reference if possible to an example of requirements of other legislation that are "at least as stringent" as those in regulation 24, but satisfaction of which would not also in fact satisfy the requirements of regulation 24 (but for regulation 24(3))—

(a)  what effect regulation 24(3) is intended to achieve, and

(b)  how the intended effect is achieved.

2.  The Department's response to question (1) is as follows:

a.  Regulation 18(3) transposes Article 7(h) of Directive 2011/65/EU and is intended to permit a manufacturer to comply with only one set of requirements for providing the name and address of the manufacturer with a product, where they manufacture a product that is subject to more than one EU regulatory regime. This is intended to reduce the regulatory burden on manufacturers where the specific details of the obligation to provide this information differ, but the differing obligations could be seen as equally effective.

b.  An example of where regulation 18(3) is necessary to achieve this result is Council Directive 93/42/EEC of 14 June 1993 concerning medical devices (Directive 93/42/EEC), which is transposed by the Medical Devices Regulations 2002/618. Medical devices can also be covered by the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Regulations 2012 (the RoHS Regulations). Under Directive 93/42/EEC, Annex I, paragraph 13, a medical device must be accompanied by certain information, including a label and instructions for use. The information required on the label includes the name or trade name and address of the manufacturer. However, there are also numerous additional pieces of information that must be on the same label, including special operating instructions, and warnings.

c.  Annex I, paragraph 13.1 of Directive 93/42/EEC states:

"As far as practicable and appropriate, the information needed to use the device safely must be set out on the device itself and/or on the packaging for each unit or, where appropriate, on the sales packaging. If individual packaging of each unit is not practicable, the information must be set out in the leaflet supplied with one or more devices."

d.  This sets a slightly different standard for when the information must be on the device, but is arguably no less stringent when read in the context of Directive 93/42/EEC. The effect of regulation 18(3) in this situation is that where a manufacturer affixes a label, including the name and address, on packaging in accordance with Directive 93/42/EEC, they would not also have to affix the name and address on the device itself (even if it would technically be possible to do so).

3.  The Department's response to question (2) is as follows:

a.  Regulation 24(3) transposes Article 9(d) and is intended to achieve the same effect for the importer as regulation 18(3) achieves for a manufacturer. The example of Directive 93/42/EEC can also be used in this context. Where a manufacturer does not have a registered place of business in a Member State, they must designate an authorised representative within the European Union. Where a device is imported into the EU, the label or outer packaging or the instructions for use must contain the name and the address of the authorised representative.

b.  In some cases, the authorised representative under Directive 93/42/EEC may also be an importer for the purposes of these Regulations. In this example, regulation 24(3) enables an importer who is also an authorised representative subject to the labelling requirements under Directive 93/42/EEC to meet the labelling requirements in the RoHS Regulations, even if it had not affixed its name and address to the device when it was technically possible to do so.

Department for Business, Innovation and Skills

21 January 2013



 
previous page contents next page


© Parliamentary copyright 2013
Prepared 5 February 2013